Avertto, an Israeli biotech company, has its sights set on revolutionizing stroke prevention.
The company’s technology — essentially a pair of small pressure sensors resting on (or in) the neck — detects changes in pulse within the carotid arteries.
The system uses artificial intelligence and deep learning technology to detect subtle changes in the patient’s pulse, which could indicate obstructions in the vessels, and thereby serve as an early signal for a brain stroke.
The device sends an alert, facilitating swift treatment within the “golden hour” that could avert severe stroke-related disability.
While other firms have dabbled in using AI to detect early stroke signs, Avertto’s combination of hardware and software gives it a potential leg up in the market as the first medical device with an AI alert of an impending stroke based on biological mimicry.
The company cites studies indicating that more than 80 percent of strokes are preventable.